Patent Assignment
Reel/Frame 015673/0776
Assignment of Assignor's Interest
Recorded: 2005-02-04
Pages: 5
Assignor
GLUCKMAN, PETER DAVID
Executed: 2004-10-12
Assignee
NEUREN PHARMACEUTICALS LTD.
LEVEL 3, 2-6 PARK AVENUE, GRAFTON, AUCKLAND, NEW ZEALAND
Covered Properties
(2)
GPE and GPE analogues/peptidomimetics and caffeinol improve sensory-motor functional recovery after stroke in rat
Application:
60/557,940 →
GPE and G2MePE in combination with caffeinol improve sensory motor functional recovery after stroke
Application:
60/572,627 →
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 29, 2004
From: NEURONZ LTD.
To: NEUREN PHARMACEUTICALS LTD.
Reel/Frame 015506/0211 →
Assignment of Assignor's Interest
Dec 29, 2004
From: NEURONZ LTD.
To: NEUREN PHARMACEUTICALS, LTD.
Reel/Frame 015507/0328 →
Merger/Change of Name
Jan 31, 2005
From: NEURONZ LIMITED
To: ENDOCRINZ LIMITED
Reel/Frame 015629/0561 →
Assignment of Assignor's Interest
Mar 27, 2006
From: GROTTA, JAMES
To: BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 017378/0626 →
Assignment of Assignor's Interest
Mar 27, 2006
From: GROTTA, JAMES
To: BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 017378/0721 →